1. Interrogation of XPO7 pathobiology in cholangiocarcinoma to elucidate therapeutic vulnerabilities. (March 2019) Authors: Ayabe, R.I.; Sinha, S.; Ahn, A.H.; Wach, M.; Ruff, S.; Ranjan, A.; Remmert, K.; van Beek, E.; Bojmar, L.; Jarnagin, W.R.; Hernandez, J.M. Journal: HPB Issue: Volume 21(2019)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Maximizing the 'Window of Opportunity' through Dynamic Live Tumor Imaging. (2022) Authors: Saif, A.; Sarvestani, A.L.; Ryan, C.; Khan, T.; Teke, M.; Verbus, E.; Remmert, K.; Lambdin, J.; Lux, S.; Luna, A.; Sinha, S.; Blakely, A.; Davis, J.; Hernandez, J. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗